Submucosal adipose tumors, while rare, present unique challenges in cancer research. These tumors, often found in the gastrointestinal tract, are composed of fatty tissue embedded within the mucosal layer. Understanding their biology is crucial as they can mimic other gastrointestinal tumors clinically and radiologically. Diagnosis typically involves endoscopic ultrasound and biopsy. Treatment options vary, including surgical resection or endoscopic removal for smaller lesions. However, recurrence rates remain a concern, necessitating further investigation into effective management strategies. Additionally, research endeavors aim to elucidate the genetic and molecular underpinnings of these tumors to develop targeted therapies, ultimately improving patient outcomes and quality of life. By unraveling the complexities of submucosal adipose tumors, researchers strive to enhance diagnostic accuracy and therapeutic interventions in the realm of gastrointestinal oncology.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China